Cx Infection Control 1-2-3

THCx serves healthcare facilities as well as other building owners with our quality control process Commissioning Infection Control  1-2-3™ to attain "Healthy Architecture" and "Healthy Environments".

Medical Research

Past Research

Research and preparation of Environmental Impact Reports for Cambridge, MA, Habitat Institute for the Environment, Belmont MA 1974 - 1975
Study of the effects of diethylstilbestrol on male offspring, Laboratory of Shirley Driscoll, MD, Brigham and Women’s Hospital, Boston MA 1974 - 1978
Vascular biology research on the mechanisms of tumor angiogenesis and mechanisms of control, Department of Surgical Research laboratory of Judah M.Folkman MD, Harvard Medical School and the MI.Children’s Hospital of Boston, Boston MA 1978 - 1984
Microbiology research of genetic expression during prenatal development by following GAP-43 using recombinant DNA techniques, Department of Neurobiology, Massachusetts General Hospital, Boston MA 1986 - 1988


Karin Gruenbaum Cancer Research Fellow 1982-1984
Soma Weiss Research Award, Harvard Medical School 1979-1981

Selected Publications

Taylor S, Haffner E; Turning a Perfect Corner, J. Amer. Physics 1979
Driscoll S and Taylor S: Effects Of In Utero Diethylstilbestrol on Male Offspring,  Obs. & Gyn 1979
Taylor S and Folkman J: Protamine is an Inhibitor of Angiogenesis: Nature (Article) 1982
Folkman J, Langer R, Taylor S: Heparin and Cortisone Fragment in the Inhibition of Tumor Angiogenesis, Science 1983
Potts J, Taylor S, et al: Inhibition of Bone Re-absorption, J. Endocrinology 1983


Stable right angle light bending in movin conditions, Hampshire College and NASA
Protamine as an angiogenesis inhibitor, Harvard Medical School, Montsanto Co.
Hexasaccharide fragment of heparin as angiogenesis inhibitor, Harvard Medical School